HALEOS LABS enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


439	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.2	1.2	0.5	0.6	1.3
16.0	16.0	15.5	16.8	19.6
109	109	84.0	97.7	98.6
562	—	—	—	—
108	108	83.5	97.1	97.4
₹1,859.60	—	—	—	—

338	338	296	291	287
32.2%	32.2%	28.4%	33.5%	34.4%
0.19×	—	—	—	—

1.73×	—	—	—	—
13.75×	—	—	—	—
22.48×	—	—	—	—
324	334	345	306	316
40.9	44.7	45.0	31.1	28.8
25.0	29.2	30.0	16.2	18.0
—	37.2	34.1	24.3	14.7
−20.6	−20.6	18.7	3.4	−33.9
—	−21.3	17.5	1.2	−35.0
—	57.9	15.3	20.9	48.6

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HALEOSLABS₹1,450.60

HALEOS LABS LIMITED

· Pharma & Health

₹ CrorePeersALBERTDAVD VALIANTLAB MEDICO MEDICAMEQ ZIMLAB AAREYDRUGS NECLIFE ANUHPHRMcap ₹439 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	438.6
- Cash, Equiv & ST Investments	1.3	0.6	0.5	1.2	1.2
+ Minority Interest	19.6	16.8	15.5	16.0	16.0
+ Total Debt	98.6	97.7	84.0	108.9	108.9
Enterprise Value	—	—	—	—	562.2
Net Debt (memo)	97.4	97.1	83.5	107.6	107.6
EV per Share	—	—	—	—	1,859.60

Total Capital	286.9	291.3	296.1	338.4	338.4
Total Debt/Total Capital	34.39	33.54	28.38	32.17	32.17
Total Debt/EV	—	—	—	—	0.19

EV/Sales	—	—	—	—	1.73
EV/EBITDA	—	—	—	—	13.75
EV/EBIT	—	—	—	—	22.48
Reference Items — Trailing FY Values
Sales	315.6	306.0	344.7	333.8	324.2
EBITDA	28.8	31.1	45.0	44.7	40.9
EBIT	18.0	16.2	30.0	29.2	25.0
Operating Cash Flow	14.7	24.3	34.1	37.2	—
Free Cash Flow	-33.9	3.4	18.7	-20.6	-20.6
FCFF (free cash flow to the firm)	-35.0	1.2	17.5	-21.3	—
Capital Expenditure	48.6	20.9	15.3	57.9	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.